16:55 EST Cellectar Biosciences (CLRB) trading halted, news pending
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLRB:
- Cellectar Biosciences transferred with Buy rating at Ladenburg
- Cellectar Biosciences price target lowered to $12 from $14 at Oppenheimer
- Cellectar Biosciences Reports Q3 2024 Financial Results
- Cellectar Biosciences reports Q3 EPS (40c), consensus (37c)
- Cellectar Biosciences sees cash runway into 2Q25